Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
inhibits specific receptors
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:developed_by |
gptkb:Allergan
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0722
|
| gptkbp:ingredients |
C20 H22 N2 O3
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_for |
treatment of neurological disorders
|
| gptkbp:related_to |
gptkb:psychologist
|
| gptkbp:targets |
neuroinflammation
|
| gptkbp:weight |
338.4 g/mol
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|